Dernières nouvelles pour Wag Group (NASDAQ:PET) Stock

Wag Group

Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.

Wag Group Co

PTT PUBLIC CO LTD NEW by PTT Public Company Ltd.

Ptt PCL

PETIQ INC COM CL A

Vibra Energia SA ADR

PetMed Express Inc

MicroPets

PETVIVO HOLDINGS INC by PetVivo Holdings Inc.

PetVivo Holdings Inc

PetVivo Holdings Inc Warrants (15/04/2026)

TDH Holdings Inc

Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.12) by 33.33 percent. This is a 50 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $76.26 million which beat the analyst consensus estimate of $52.71 million by 44.67 percent.

Earnings

Earnings Beats

Earnings Misses

News

VRNA

Correction://Verona Pharma Q1 GAAP Earning per ADS $(0.16) Misses $(0.12) Estimate, Sales $76.26M Beat $52.71M Estimate

Guidance

Polaris Sees Q2 FY25 Sales Guidance Of $1.6B-$1.8B

WIIM

SANM

Sanmina shares are trading lower after the company reported Q2 financial results and issued Q3 guidance below estimates.

NXPI

NXP Semiconductors shares are trading lower after the company reported Q1 financial results and issued Q2 EPS guidance with its midpoint below estimates. The company announced CEO Kurt Sievers will retire at the end of 2025.

Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 40.63 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $76.26 million which beat the analyst consensus estimate of $52.71 million by 44.67 percent.

Verona Pharma Q1 GAAP Earning per ADS $(0.19) Misses $(0.12) Estimate, Sales $76.26M Beat $52.71M Estimate

UCTT

Ultra Clean Holdings shares are trading lower after the company reported worse-than-expected Q1 financial result and issued Q2 guidance below estimates.

Enterprise Prods Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>) reported quarterly earnings of $0.64 per share which missed the analyst consensus estimate of $0.72 by 11.11 percent. This is a 3.03 percent decrease over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $15.42 billion which beat the analyst consensus estimate of $14.05 billion by 9.73 percent. This is a 4.45 percent increase over sales of $14.76 billion the same period last year.

Enterprise Prods Partners Q1 EPS $0.64 Misses $0.72 Estimate, Sales $15.42B Beat $14.05B Estimate

BYON

Beyond shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

TVGN

Tevogen Bio Holdings shares are trading higher after the company reaffirmed its oncology pipeline revenue forecast, projecting $1 billion in its launch year and a cumulative five-year estimate of $10 billion to $14 billion.

OKTA

Okta shares are trading higher after the company announced it will replace Berry Global Group in the S&P Midcap 400, effective before the opening of trading on Thursday, May 1.

General

MGRM

AI Robotic Company Monogram Obtains Regulatory Approval From India's Central Drugs Standard Control Organization To Import mBôs TKA System To Conduct Clinical Trials

Ares Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NASDAQ">ARCC</a>) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.54 by 7.41 percent. This is a 15.25 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $732.00 million which missed the analyst consensus estimate of $777.10 million by 5.80 percent. This is a 4.42 percent increase over sales of $701.00 million the same period last year.

ARCC

Ares Capital Q1 Adj. EPS $0.50 Misses $0.54 Estimate, Sales $732.00M Miss $777.10M Estimate

ABEO

Abeona Therapeutics shares are trading higher after the company announced FDA approval of ZEVASKYN for treating wounds in patients with recessive dystrophic epidermolysis bullosa.

JOBY

Joby Aviation Completes Flights With A Full Transition From Vertical To Cruise Flight And Back Again With A Pilot Onboard

Polaris Is Withdrawing Full Year 2025 Guidance Due To Trade And Economic Uncertainty

Offerings

BSGM

BioSig Technologies Issued 2.75M Restricted Shares to Service Providers for Business Development Services

<ul>
<li>ZEVASKYN fills a critical need for people living with RDEB, a debilitating dermatological condition with no cure.</li>
<li>Approval based on the pivotal Phase 3 VIITAL study, showing ZEVASKYN resulted in significant wound healing and pain reduction after a single treatment with a favorable safety profile.</li>
<li>ZEVASKYN to be available through Qualified Treatment Centers beginning in 3Q 2025.</li>
<li>Abeona Assist patient services program offers personalized support for eligible patients and families throughout their treatment journey with ZEVASKYN.</li>
<li>Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA</li>
</ul>

Biotech

Health Care

The FDA Approves Abeona Therapeutics' Zevaskyn (Prademagene Zamikeracel) Gene-modified Cellular Sheets, Also Known As Pz-cel, As The First And Only Autologous Cell-based Gene Therapy For Wounds In Adult And Pediatric Patients With Recessive Dystrophic Epidermolysis Bullosa

SentinelOne Releases Purple AI 'Athena' With Agentic AI Capabilities To Mirror The Deep Security Reasoning

Polaris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate of $(0.91) by 1.1 percent. This is a 491.3 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $1.54 billion which met the analyst consensus estimate. This is a 11.53 percent decrease over sales of $1.74 billion the same period last year.

Polaris Q1 Adj. EPS $(0.90) Beats $(0.91) Estimate, Sales $1.54B Inline

Honeywell Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) narrows FY2025 GAAP EPS guidance from $9.39-$9.79 to $9.48-$9.78 vs $9.74 analyst estimate..

Honeywell Intl Narrows FY2025 GAAP EPS Guidance from $9.39-$9.79 to $9.48-$9.78 vs $9.74 Est

Press Releases

Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference

Wag! Group Co. Announces Proposed Public Offering of Common Stock

Wag! Group Co. Announces Pricing of Public Offering of $10 Million of Shares of Common Stock

Wag! To Report Second Quarter 2024 Financial Results on August 7, 2024

Wag! Reports Second Quarter 2024 Results

Wag! To Report Third Quarter 2024 Financial Results on November 13, 2024

Wag! Reports Third Quarter 2024 Results

"Game-Changers to Watch CRDL, RMSG, WORX, PET and more…Innovative Companies inside"

Wag! To Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025

Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value

ACNT

AERT

AEYE

AIRG

AMPX

AMRK

ARQQ

ASPN

ATEX

BBSI

BKSY

BNZI

BREZ

BTBT

BYRN

CORZ

CPSS

CRDL

CRKN

DEFTF

DUOT

ELVA

FTHM

GAIA

GCTS

GENK

HEAR

HTCR

JTAI

LINK

LTRX

MAPPF

MIGI

MYPS

NATR

OOMA

PHUN

PRLB

PRSO

PXDT

QTRHF

QUISF

RMSG

SNCR

SNPO

SOWG

SSTI

TRUE

TSX:KITS

TSX:QTRH

TSX:QUIS

TYGO

VTSI

WKHS

WORX

ZCAR

Allurion Technologies

The Beachbody Company, Inc. Class A Common Stock

Beachbody Co

Carriage Servs

E-Home Household Service Holdings Limited - Ordinary shares

E-Home Household Service

European Wax Center, Inc. - Class A Common Stock

European Wax Center

Frontdoor

H&R Block

Mister Car Wash

Mixed Martial Arts Group Limited Ordinary Shares

Mixed Martial Arts Group

MEDIROM Healthcare Technologies Inc. - American Depositary Share

MEDIROM Healthcare Techs

OneSpaWorld Holdings Limited - Common Shares

OneSpaWorld Hldgs

Regis

Service Corporation International Common Stock

Service Corp Intl

SunCar Technology Group Inc. - Ordinary Shares

SunCar Tech Gr

WW International

XWELL

YSX Tech. Co., Ltd - Class A Ordinary Shares

YSX Tech

DA Davidson

Oppenheimer

Roth MKM

Lake Street

Chardan Capital

Screenshot 2024-02-27 at 6.34.08 PM

Emerging Markets

Markets

CHWY

FRPT

More Millennials Are Opting For Pets Over Children As Pet Industry Continues To Grow

Comments

Wag Group

Actualités

Dernières nouvelles pour Wag Group (NASDAQ:PET) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL